Orexigen (Nasdaq: OREX) has filed an amended S-1 statement with the SEC. The Company now expects the IPO price to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE